Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Wiegand

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Heart (British Cardiac Society)|March 17, 1999
Differential effects of defibrillation on systemic and cardiac sympathetic activityF Bode, U Wiegand, W Raasch, et al.
Gene|December 22, 1993
Cloning of the cDNA encoding human brain trypsinogen and characterization of its productU Wiegand, S Corbach, A Minn, et al.
Pacing and Clinical Electrophysiology : PACE|April 6, 2000
Soluble L-selectin and neutrophil derived oxidative stress after pacing induced myocardial ischemia in chronic stable coronary artery diseaseE Giannitsis, I Tettenborn, U Wiegand, et al.
Zeitschrift Fur Kardiologie|February 9, 2000
Clinical and angiographic outcome of patients with acute inferior myocardial infarctionE Giannitsis, F Hartmann, U Wiegand, et al.
Oncology|January 1, 1985
Oral high-dose medroxyprogesterone acetate (MPA) treatment: cortisol/MPA serum profiles in relation to breast cancer regressionM Mahlke, H J Grill, P Knapstein, et al.
Pacing and Clinical Electrophysiology : PACE|February 25, 1998
Neutrophil-derived oxidative stress after myocardial ischemia induced by incremental atrial pacingE Giannitsis, I Tettenborn, U Wiegand, et al.
Journal of Hepatology|January 1, 1993
Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848)V Gross, E Treher, K Haag, et al.
Psychotherapy and Psychosomatics|December 20, 2005
Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function?D Benninghoven, A Kaduk, U Wiegand, et al.
Heart (British Cardiac Society)|June 1, 1997
Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarctionE Giannitsis, J Potratz, U Wiegand, et al.
Das Deutsche Gesundheitswesen|November 11, 1971
[Complement fixation test--a sensitive method for the detection of Australia (SH) antigen]A Tacke, B Schneeweiss, G Geserick, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Heart (British Cardiac Society)|March 17, 1999
Differential effects of defibrillation on systemic and cardiac sympathetic activityF Bode, U Wiegand, W Raasch, et al.
Gene|December 22, 1993
Cloning of the cDNA encoding human brain trypsinogen and characterization of its productU Wiegand, S Corbach, A Minn, et al.
Pacing and Clinical Electrophysiology : PACE|April 6, 2000
Soluble L-selectin and neutrophil derived oxidative stress after pacing induced myocardial ischemia in chronic stable coronary artery diseaseE Giannitsis, I Tettenborn, U Wiegand, et al.
Zeitschrift Fur Kardiologie|February 9, 2000
Clinical and angiographic outcome of patients with acute inferior myocardial infarctionE Giannitsis, F Hartmann, U Wiegand, et al.
Oncology|January 1, 1985
Oral high-dose medroxyprogesterone acetate (MPA) treatment: cortisol/MPA serum profiles in relation to breast cancer regressionM Mahlke, H J Grill, P Knapstein, et al.
Pacing and Clinical Electrophysiology : PACE|February 25, 1998
Neutrophil-derived oxidative stress after myocardial ischemia induced by incremental atrial pacingE Giannitsis, I Tettenborn, U Wiegand, et al.
Journal of Hepatology|January 1, 1993
Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848)V Gross, E Treher, K Haag, et al.
Psychotherapy and Psychosomatics|December 20, 2005
Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function?D Benninghoven, A Kaduk, U Wiegand, et al.
Heart (British Cardiac Society)|June 1, 1997
Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarctionE Giannitsis, J Potratz, U Wiegand, et al.
Das Deutsche Gesundheitswesen|November 11, 1971
[Complement fixation test--a sensitive method for the detection of Australia (SH) antigen]A Tacke, B Schneeweiss, G Geserick, et al.
Pageof 5